{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:43:55Z","timestamp":1776901435288,"version":"3.51.2"},"publisher-location":"New York, NY","reference-count":38,"publisher":"Springer US","isbn-type":[{"value":"9781071651971","type":"print"},{"value":"9781071651988","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5198-8_9","type":"book-chapter","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:07:44Z","timestamp":1776899264000},"page":"127-147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Generation and Characterization of Patient-Derived Human Pluripotent Stem Cell Lines for Retinal Gene Therapy"],"prefix":"10.1007","author":[{"given":"Nathan","family":"Ehrenreich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibaud","family":"Metais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Garita-Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"9_CR1","doi-asserted-by":"crossref","unstructured":"Seifirad S (2014) An emerging need for developing new models for myocardial infarction as a chronic complex disease: lessons learnt from animal vs human studies on cardioprotective effects of Erythropoietin in reperfused myocardium. Front Physiol 5","DOI":"10.3389\/fphys.2014.00044"},{"key":"9_CR2","doi-asserted-by":"crossref","unstructured":"Seifirad S, Haghpanah V (2019) Inappropriate modeling of chronic and complex disorders: How to reconsider the approach in the context of predictive, preventive and personalized medicine, and translational medicine. EPMA J 10:195","DOI":"10.1007\/s13167-019-00176-z"},{"key":"9_CR3","doi-asserted-by":"crossref","unstructured":"Charitos IA, Ballini A, Cantore S et al (2021) Stem cells: a historical review about biological, religious, and ethical issues. Stem Cells Int","DOI":"10.1155\/2021\/9978837"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663","journal-title":"Cell"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nbt1374","volume":"26","author":"M Nakagawa","year":"2008","unstructured":"Nakagawa M, Koyanagi M, Tanabe K et al (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 26:101","journal-title":"Nat Biotechnol"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.stem.2013.06.019","volume":"13","author":"N Montserrat","year":"2013","unstructured":"Montserrat N, Nivet E, Sancho-Martinez I et al (2013) Reprogramming of human fibroblasts to pluripotency with lineage specifiers. Cell Stem Cell 13:341","journal-title":"Cell Stem Cell"},{"key":"9_CR7","doi-asserted-by":"crossref","unstructured":"Kim EY, Page P, Dellefave-Castillo LM et al (2016) Direct reprogramming of urine-derived cells with inducible MyoD for modeling human muscle disease. Skelet Muscle 6","DOI":"10.1186\/s13395-016-0103-9"},{"key":"9_CR8","doi-asserted-by":"crossref","unstructured":"Zhou T, Benda C, Duzinger S, et al (2011) Generation of induced pluripotent stem cells from urine 22","DOI":"10.1681\/ASN.2011010106"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.stem.2010.06.004","volume":"7","author":"YH Loh","year":"2010","unstructured":"Loh YH, Hartung O, Li H et al (2010) Reprogramming of T cells from human peripheral blood. Cell Stem Cell 7:15","journal-title":"Cell Stem Cell"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.stem.2010.06.002","volume":"7","author":"J Staerk","year":"2010","unstructured":"Staerk J, Dawlaty MM, Gao Q et al (2010) Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 7:20","journal-title":"Cell Stem Cell"},{"key":"9_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nature06534","volume":"451","author":"IH Park","year":"2008","unstructured":"Park IH, Zhao R, West JA et al (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141","journal-title":"Nature"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nature11629","volume":"492","author":"A Abyzov","year":"2012","unstructured":"Abyzov A, Mariani J, Palejev D et al (2012) Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 492:438","journal-title":"Nature"},{"key":"9_CR13","doi-asserted-by":"crossref","unstructured":"Hotta A, Ellis J (2008), Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states","DOI":"10.1002\/jcb.21912"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nmeth.1323","volume":"6","author":"K Yusa","year":"2009","unstructured":"Yusa K, Rad R, Takeda J et al (2009) Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nat Methods 6:363","journal-title":"Nat Methods"},{"key":"9_CR15","doi-asserted-by":"crossref","unstructured":"Yang W (2014) iPSC reprogramming from human peripheral blood using Sendai virus mediated gene transfer. Stembook","DOI":"10.3824\/stembook.1.73.1"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"14234","DOI":"10.1073\/pnas.1103509108","volume":"108","author":"H Ban","year":"2011","unstructured":"Ban H, Nishishita N, Fusaki N et al (2011) Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci USA 108:14234","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2183\/pjab.85.348","volume":"85","author":"N Fusaki","year":"2009","unstructured":"Fusaki N, Ban H, Nishiyama A et al (2009) Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 85:348","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1089\/scd.2013.0621","volume":"23","author":"K Hu","year":"2014","unstructured":"Hu K (2014) Vectorology and factor delivery in induced pluripotent stem cell reprogramming. Stem Cells Dev 23:1301","journal-title":"Stem Cells Dev"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"558","DOI":"10.5966\/sctm.2013-0006","volume":"2","author":"L Ye","year":"2013","unstructured":"Ye L, Muench MO, Fusaki N et al (2013) Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by sendai viral vectors. Stem Cells Transl Med 2:558","journal-title":"Stem Cells Transl Med"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"16698","DOI":"10.1073\/pnas.0905245106","volume":"106","author":"JS Meyer","year":"2009","unstructured":"Meyer JS, Shearer RL, Capowski EE et al (2009) Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci USA 106:16698","journal-title":"Proc Natl Acad Sci USA"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"8518","DOI":"10.1073\/pnas.1324212111","volume":"111","author":"S Reichman","year":"2014","unstructured":"Reichman S, Terray A, Slembrouck A et al (2014) From confluent human iPS cells to self-forming neural retina and retinal pigmented epithelium. Proc Natl Acad Sci U S A 111:8518","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9_CR22","doi-asserted-by":"crossref","unstructured":"Zhong X, Gutierrez C, Xue T et al (2014) Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs. Nat Commun 5","DOI":"10.1038\/ncomms5047"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13619-021-00097-1","volume":"10","author":"X Zhang","year":"2021","unstructured":"Zhang X, Wang W, Jin ZB (2021) Retinal organoids as models for development and diseases. Cell Regen 10:33","journal-title":"Cell Regen"},{"key":"9_CR24","doi-asserted-by":"crossref","unstructured":"Garita-Hernandez M, Guibbal L, Toualbi L et al (2018) Optogenetic light sensors in human retinal organoids. Front Neurosci 12","DOI":"10.3389\/fnins.2018.00789"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.stemcr.2017.07.022","volume":"9","author":"A Gonzalez-Cordero","year":"2017","unstructured":"Gonzalez-Cordero A, Kruczek K, Naeem A et al (2017) Recapitulation of human retinal development from human pluripotent stem cells generates transplantable populations of cone photoreceptors. Stem Cell Reports 9:820","journal-title":"Stem Cell Reports"},{"key":"9_CR26","doi-asserted-by":"crossref","unstructured":"Sharma R, Khristov V, Rising A et al (2019) Clinical-grade stem cell-derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs. Sci Transl Med 11","DOI":"10.1126\/scitranslmed.aat5580"},{"key":"9_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.stemcr.2020.05.007","volume":"15","author":"A Lane","year":"2020","unstructured":"Lane A, Jovanovic K, Shortall C et al (2020) Modeling and rescue of RP2 retinitis Pigmentosa using iPSC-derived retinal organoids. Stem Cell Reports 15:67","journal-title":"Stem Cell Reports"},{"key":"9_CR28","doi-asserted-by":"crossref","unstructured":"Sanjurjo-Soriano C, Jimenez-Medina C, Erkilic N, et al (2023) USH2A variants causing retinitis pigmentosa or Usher syndrome provoke differential retinal phenotypes in disease-specific organoids. 4, Hum Genet Genomics Adv","DOI":"10.1016\/j.xhgg.2023.100229"},{"key":"9_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47253-0","volume":"15","author":"R Atkinson","year":"2024","unstructured":"Atkinson R, Georgiou M, Yang C et al (2024) PRPF8-mediated dysregulation of hBrr2 helicase disrupts human spliceosome kinetics and 5\u2032-splice-site selection causing tissue-specific defects. Nat Commun 15:3138","journal-title":"Nat Commun"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41536-022-00235-6","volume":"7","author":"A Rodrigues","year":"2022","unstructured":"Rodrigues A, Slembrouck-Brec A, Nanteau C et al (2022) Modeling PRPF31 retinitis pigmentosa using retinal pigment epithelium and organoids combined with gene augmentation rescue. NPJ Regen Med 7:39","journal-title":"NPJ Regen Med"},{"key":"9_CR31","doi-asserted-by":"crossref","unstructured":"Vergara MN, Flores-Bellver M, Aparicio-Domingo S, et al (2017) Three-dimensional automated reporter quantification (3D-ARQ) technology enables quantitative screening in retinal organoids. 144","DOI":"10.1242\/dev.146290"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"7293","DOI":"10.1038\/s41467-021-27488-x","volume":"12","author":"R Sharma","year":"2021","unstructured":"Sharma R, George A, Nimmagadda M et al (2021) Epithelial phenotype restoring drugs suppress macular degeneration phenotypes in an iPSC model. Nat Commun 12:7293","journal-title":"Nat Commun"},{"key":"9_CR33","doi-asserted-by":"crossref","unstructured":"Burnight ER, Gupta M, Wiley LA, et al (2017) Using CRISPR-Cas9 to generate gene-corrected autologous iPSCs for the treatment of inherited retinal degeneration. 25","DOI":"10.1016\/j.ymthe.2017.05.015"},{"key":"9_CR34","doi-asserted-by":"crossref","unstructured":"Garita-Hernandez M, Routet F, Guibbal L et al (2020) AAV-mediated gene delivery to 3D retinal organoids derived from human induced pluripotent stem cells. Int J Mol Sci 21","DOI":"10.3390\/ijms21030994"},{"key":"9_CR35","doi-asserted-by":"crossref","unstructured":"Khabou H, Garita-Hernandez M, Chaffiol A et al (2018) Noninvasive gene delivery to foveal cones for vision restoration. JCI Insight 3","DOI":"10.1172\/jci.insight.96029"},{"key":"9_CR36","first-page":"750","volume":"64","author":"M Garita-Hernandez","year":"2023","unstructured":"Garita-Hernandez M, Zeaiter M, Pierce EA (2023) Optimized prime editing efficiently generates mutations in hiPSCs to model inherited retinal degeneration. Invest Ophthalmol Vis Sci 64:750\u2013750","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9_CR37","volume":"64","author":"E Galdikaite-Braziene","year":"2023","unstructured":"Galdikaite-Braziene E, Serrano JCC, Garita-Hernandez M et al (2023) Characterization of EYS in human iPSC-derived retinal organoids. Invest Ophthalmol Vis Sci 64:3186\u20133186","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9_CR38","doi-asserted-by":"crossref","unstructured":"Brydon EM, Bronstein R, Buskin A et al (2019) AAV-mediated gene augmentation therapy restores critical functions in mutant PRPF31+\/\u2212 iPSC-derived RPE cells. Mol Ther Methods Clin Dev 15","DOI":"10.1016\/j.omtm.2019.10.014"}],"container-title":["Methods in Molecular Biology","Retinal Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5198-8_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:07:47Z","timestamp":1776899267000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5198-8_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071651971","9781071651988"],"references-count":38,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5198-8_9","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 April 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}